Atrys Health, S.A. (BME:ATRY)
Spain
· Delayed Price · Currency is EUR 2.980
0.00 (0.00%)
Apr 2, 2025, 1:53 PM CET
Atrys Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -31.77 | -45.59 | -23.15 | -23.26 | -5.55 | Upgrade
|
| Depreciation & Amortization | 29.04 | 23.21 | 25.22 | 16.7 | 4.11 | Upgrade
|
| Other Amortization | - | 6.47 | 5.12 | 4.09 | 1.87 | Upgrade
|
| Asset Writedown & Restructuring Costs | 18.69 | 6.18 | 6.64 | 1.5 | 0.14 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.34 | - | 0.83 | - | - | Upgrade
|
| Other Operating Activities | -4.99 | 9.77 | -11.99 | 5.65 | 1.7 | Upgrade
|
| Change in Accounts Receivable | -7.36 | 0.36 | 0.5 | -2.74 | -1.8 | Upgrade
|
| Change in Inventory | -0.02 | -0.46 | -0.3 | -0.12 | 0.04 | Upgrade
|
| Change in Accounts Payable | 2.8 | 0.56 | -1.99 | 4.98 | -0.95 | Upgrade
|
| Change in Other Net Operating Assets | -2.05 | -1.57 | -11.95 | -2.1 | -0.95 | Upgrade
|
| Operating Cash Flow | 3 | -1.09 | -15.43 | 4.69 | -1.4 | Upgrade
|
| Capital Expenditures | -4.25 | -6.25 | -6.77 | -4.22 | -3.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | - | - | 18.19 | - | Upgrade
|
| Cash Acquisitions | - | -24.08 | -75.81 | -10.82 | -46.72 | Upgrade
|
| Divestitures | - | 39.72 | 14 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -8.89 | -6.9 | -8.39 | -4.34 | -2.1 | Upgrade
|
| Investment in Securities | -0.06 | -2.09 | -3.61 | -1.25 | -0.07 | Upgrade
|
| Investing Cash Flow | -12.95 | 0.4 | -80.59 | -2.45 | -52.08 | Upgrade
|
| Long-Term Debt Issued | 29.37 | 18.18 | 51.9 | 142.92 | 46.77 | Upgrade
|
| Long-Term Debt Repaid | -40.85 | -10.27 | -39.6 | -128.71 | -18.46 | Upgrade
|
| Net Debt Issued (Repaid) | -11.48 | 7.91 | 12.3 | 14.2 | 28.31 | Upgrade
|
| Issuance of Common Stock | - | 0.29 | 82.48 | - | 34.32 | Upgrade
|
| Repurchase of Common Stock | -0.03 | - | - | -0.12 | - | Upgrade
|
| Financing Cash Flow | -11.51 | 8.19 | 94.77 | 14.08 | 62.63 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.04 | 0.42 | 1.32 | - | Upgrade
|
| Net Cash Flow | -21.46 | 7.53 | -0.83 | 17.65 | 9.15 | Upgrade
|
| Free Cash Flow | -1.25 | -7.34 | -22.2 | 0.47 | -4.59 | Upgrade
|
| Free Cash Flow Margin | -0.56% | -3.56% | -13.60% | 0.38% | -13.58% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.10 | -0.33 | 0.01 | -0.16 | Upgrade
|
| Cash Interest Paid | - | 25.31 | 15.22 | 9.97 | 2.49 | Upgrade
|
| Cash Income Tax Paid | - | 2.21 | 2.48 | 1.09 | 0.39 | Upgrade
|
| Levered Free Cash Flow | 36.02 | -28.29 | 21.48 | -5.09 | -3.72 | Upgrade
|
| Unlevered Free Cash Flow | 50.71 | -7.64 | 30.56 | 1.81 | -2.26 | Upgrade
|
| Change in Net Working Capital | -29.97 | 23.17 | -22.1 | 7.89 | 4.95 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.